OF THE CQIB
of capital raised
Years of experience in incubation and acceleration
An inspiring business model
THE CQIB MODEL IS RECOGNIZED INTERNATIONALLY
In 2002, the CQIB won the highest international recognition for incubators, the "Randall M. Whaley Incubator of the Year", awarded by the International Business Innovation Association (INBIA), an organization bringing together over 1,200 business incubators, from 62 countries.
In 2013, the CQIB was awarded as well "Best Canadian Incubator" at the Backbone Innovation summits, a Canadian event, where young tech companies present to a panel of experts.
Proven successes in life sciences
Over the years, the CQIB has fostered the growth of more than 100 companies in life sciences and medical technologies
What do these startups have in common ?
A passion for innovation, the desire to improve quality of life and the desire to promote research and discovery in Quebec
Their key success factors:
Research infrastructure, collaboration, strategic and operational advice, particularly in financing and commercialization, are the keys to success offered by the CQIB. Its environment supports ambition for enterprising in large-scale projects, or exports.
A word from our stakeholders
START YOUR BUSINESS IN LIFE SCIENCES OR MEDICAL TECHNOLOGIES
« The CQIB is an excellent turnkey solution for start-ups (...) What we have learned in such a short time is invaluable in terms of relationship building and professional presentation. Our relationship with the CQIB has greatly contributed to the success and growth of our New World Laboratories »
- Mr. Eric Ahlfors, CEO and scientific director
SOFT LANDING IN CANADA
« It was only at the CQIB that we found the high-tech equipment necessary for our research. In addition, its location offers access to an abundance of good researchers, thanks to the four universities in the region »
- Richard Andrews, CEO and exécutive director of Azitra, USA
Choosing the CQIB and its advantages
Integrate into a stimulating environment in the city of Biotech: More than 100 companies, 11 research centers and $3 billion in investments.
Forge strategic links with key players in the life sciences, such as Roche Diagnostics, Servier, GSK, Bausch Health, Charles River, Sanofi, among others.
Benefit from the resource of the National Institut for Scientific Research (INRS), Center Armand-Frappier. More than 47 professor-researchers, 160 students and postdoctoral fellows.
Take advantage of 13,000 sf (2,500 m2) of laboratories with preclinical facilities and high-end best-in-class equipment.
Benefit from consulting and advisory services based on more than 25 years of experience in incubating and accelerating businesses in the life sciences.
Access the National Center for Experimental Biotechnology (CNBE) with 78 multifunctional accommodation rooms in BPA certified facilities.
Evolve in a business environment valued by the municipal, regional and provincial political class.